Autopsy report · NCT01564732

Multicenter Prospective Randomized Controlled Trial of Plicated Laparoscopic Adjustable Gastric Banding

“Sponsor withdrew funding.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 6 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 1 year 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Dana Portenier, MD

Sponsor type

University, hospital or other

Conditions

Morbid Obesity

Interventions

Standard-LAGB; Plicated-LAGB

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (92% match in meaning)
• Cognitive Effects of Bioavailable Curcumin
  “Sponsor withdrew.” (90% match in meaning)
• Lucentis for New Onset Neovascular Glaucoma
  “Company withdrew funding/sponsorship” (87% match in meaning)
• An Exploratory Investigation to Assess Changes in Quality of Life for Individuals With Type 2 Diabetes After Taking a Meal-replacement Shake.
  “Sponsor withdrawn” (86% match in meaning)
• Dose Escalation Study of Nelfinavir Plus MLN9708 in Patients With Advanced Solid Tumors or Lymphoma
  “Sponsor withdrew support” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.